pubmed-article:9632125 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C0011849 | lld:lifeskim |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C0497406 | lld:lifeskim |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C0043096 | lld:lifeskim |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:9632125 | lifeskim:mentions | umls-concept:C1947946 | lld:lifeskim |
pubmed-article:9632125 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:9632125 | pubmed:dateCreated | 1998-8-27 | lld:pubmed |
pubmed-article:9632125 | pubmed:abstractText | Weight change and glycaemic control in 132 diabetic patients previously treated for 1 year by four different methods aimed at weight loss were reanalysed 4 years after the outset. The four treatment groups comprised clinic visits, home visits, behavioural group therapy, and dexfenfluramine given for the initial 3 months followed by clinic visits. When analysed on an intention to treat basis only the dexfenfluramine group maintained a significant weight loss at year 4 (mean -2.46 kg) with 43% of patients losing 3 kg or more; HBA1c was not decreased. The other treatment groups showed overall weight regain from year 1 to year 4. Within the home visit group however, the number of patients losing at least 3 kg doubled between years 1 (21%) and 4 (38%). When analysed on a completion basis, weight loss in the dexfenfluramine group was significant in females but not in males at year 4. During the 4 years of observation a cohort of 54 patients reflecting our routine clinic practice gained on average 0.35 kg. Although now withdrawn, the use of an appetite suppressant dexfenfluramine for just 3 months would appear to have a long-term advantage on weight loss in this diabetic population, although the weight lost was not associated with improvement in glycaemic control. | lld:pubmed |
pubmed-article:9632125 | pubmed:language | eng | lld:pubmed |
pubmed-article:9632125 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9632125 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9632125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9632125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9632125 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9632125 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9632125 | pubmed:month | Jun | lld:pubmed |
pubmed-article:9632125 | pubmed:issn | 0742-3071 | lld:pubmed |
pubmed-article:9632125 | pubmed:author | pubmed-author:JungR TRT | lld:pubmed |
pubmed-article:9632125 | pubmed:author | pubmed-author:NewtonR WRW | lld:pubmed |
pubmed-article:9632125 | pubmed:author | pubmed-author:ManningR MRM | lld:pubmed |
pubmed-article:9632125 | pubmed:author | pubmed-author:LeeseG PGP | lld:pubmed |
pubmed-article:9632125 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9632125 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:9632125 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9632125 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9632125 | pubmed:pagination | 497-502 | lld:pubmed |
pubmed-article:9632125 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:meshHeading | pubmed-meshheading:9632125-... | lld:pubmed |
pubmed-article:9632125 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9632125 | pubmed:articleTitle | The comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four-year follow-up. | lld:pubmed |
pubmed-article:9632125 | pubmed:affiliation | The Diabetes Centre, Ninewells Hospital and Medical School, Dundee, Scotland. | lld:pubmed |
pubmed-article:9632125 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9632125 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:9632125 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:9632125 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:9632125 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9632125 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9632125 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9632125 | lld:pubmed |